Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | MYC | P01106 | 1/20 | 0.31 |
| ▸ | MAX | P61244 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26948755 | 0.79 | GAA (0.49) | MEN1KMT2AMAPTL3MBTL1GAA | |
| SCHEMBL8726354 | 0.78 | MEN1 (0.75) | MEN1KMT2AMAPTL3MBTL1GAA | |
| SCHEMBL26948734 | 0.78 | GAA (0.45) | MEN1KMT2AMAPTL3MBTL1GAA | |
| SCHEMBL6922342 | 0.77 | LMNA (0.41) | MAPTGAAALDH1A1LMNAHTT | |
| SCHEMBL26948737 | 0.75 | MEN1 (0.43) | MEN1KMT2AMAPTL3MBTL1GAA | |
| SCHEMBL2558092 | 0.75 | LMNA (0.35) | ALDH1A1LMNAHTTSMN1; SMN2POLB | |
| SCHEMBL8726551 | 0.74 | MAPT (0.71) | MEN1KMT2AMAPTL3MBTL1GAA | |
| SCHEMBL8728068 | 0.71 | GAA (0.55) | MEN1KMT2AL3MBTL1GAAALDH1A1 | |
| SCHEMBL8726301 | 0.70 | MEN1 (0.49) | MEN1KMT2AMAPTL3MBTL1GAA | |
| SCHEMBL8726264 | 0.70 | MEN1 (0.46) | MEN1KMT2AMAPTL3MBTL1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399423-A1 | POLYMERIC DISINFECTANTS AND USES THEREOF | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2023-12-14 | — | — | US | disclosed |
| US-20230399423-A1 | POLYMERIC DISINFECTANTS AND USES THEREOF | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2023-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399423-A1 | POLYMERIC DISINFECTANTS AND USES THEREOF | CUTA, PRKDC, PIK3C3 | MEN1 2697/4885KMT2A 388/4885MAPT 4658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.